Hypothesis: that rheumatoid arthritis will disappear
Buchanan, W.W.; Murdoch, R.M.
Journal of Rheumatology 6(3): 324-329
1979
ISSN/ISBN: 0315-162X PMID: 385872 Document Number: 142259
The first unequivocally clear description of rheumatoid arthritis occurred in 1800. It is possible, however, that the disease existed in earlier times and that Emperor Constantine IX Monomachus (circa 980-1055) was a sufferer. The disease is common today in all races throughout the world. The features of rheumatoid arthritis are consistent with its being an infection, perhaps a slow-virus infection. On the basis of behaviour of other bacterial and viral infections, it is possible that we may now expect the current pandemic to disappear. Perhaps by the end of the next century it will be mild and rare or even non-existent.
Document emailed within 1 workday
Related Documents
Salmon, S.E.; Dalton, W.S. 1996: Relevance of multidrug resistance to rheumatoid arthritis: development of a new therapeutic hypothesis Journal of Rheumatology. Supplement 44: 97-101Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444
Scherler, M. 1978: Poncet--rheumatoid arthritis. Four cases of rheumatoid arthritis treated with tuberculostatics (author's transl1 Therapeutische Umschau. Revue Therapeutique 35(3): 201-206
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Singh, N.; Garg, S.C. 1988: Rheumatoid arthritis presenting as arthritis mutilans with rheumatoid lung Journal of the Indian Medical Association 86(1): 14-15
Yu, C.; Li, M.; Duan, X.; Fang, Y.; Li, Q.; Wu, R.; Liu, S.; Wang, Y.; Wu, Z.; Shi, X.; Jiang, Z.; Wang, Y.; Hsieh, E.D.; Jin, S.; Jiang, N.; Wang, Q.; Zhao, Y.; Tian, X.; Zeng, X. 2018: Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis Clinical and Experimental Rheumatology 36(5): 836-840
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Lineker, S.C.; Badley, E.M.; Hughes, E.A.; Bell, M.J. 1997: Development of an instrument to measure knowledge in individuals with rheumatoid arthritis: the ACREU rheumatoid arthritis knowledge questionnaire Journal of Rheumatology 24(4): 647-653
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Førre, O.; Dobloug, J.H.; Natvig, J.B. 1982: Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis: in vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reaction Scandinavian Journal of Immunology 15(2): 227-231
Coaccioli, S.; Pinoca, F.; Giuliani, M.; Landucci, P.; Sabatini, C.; Puxeddu, A. 2007: Definition of adult-onset rheumatoid arthritis from elderly-onset rheumatoid arthritis by studying T-lymphocyte subpopulations, their soluble receptors and soluble receptor of interleukin-2 La Clinica Terapeutica 158(4): 303-306
Müller-Hermelink, H.K.; Parwaresch, M.R. 1979: Rheumatoid arthritis of the hand. Pathology of rheumatoid arthritis Zeitschrift für Orthopadie und ihre Grenzgebiete 117(4): 497-504
Sahin, G.; Guler, H.; Incel, N.; Sezgin, M.; As, I. 2006: Soft tissue composition, axial bone mineral density, and grip strength in postmenopausal Turkish women with early rheumatoid arthritis: Is lean body mass a predictor of bone mineral density in rheumatoid arthritis? International Journal of Fertility and Women's Medicine 51(2): 70-74
Jarner, D.; Jarlov, N.V.; Larsen, J.H. 1977: Yersinia arthritis and chronic collagenosis. II. Cases of Yersinia arthritis with prolonged course and development of rheumatoid arthritis Ugeskrift for Laeger 139(25): 1481-1484
Vlak, T.; Jajić, I. 1992: The effect of gold salts on rheumatoid factor dynamics in patients with rheumatoid arthritis Reumatizam 39(1): 11-13
Goodson, N.J.; Farragher, T.M.; Symmons, D.P.M. 2008: Rheumatoid factor, smoking, and disease severity: associations with mortality in rheumatoid arthritis Journal of Rheumatology 35(6): 945-949